This package measures blood glucose levels, including HbA1c levels. The HbA1c (hemoglobin A1c) test measures average blood sugar level over an extended period (8-12 weeks) and is a useful tool for both detecting and/or monitoring diabetes. Consistently elevated blood sugars can increase risk of heart disease, kidney damage and stroke thus monitoring and maintaining the right blood sugar levels is essential to prevent complications. It also includes a set of screenings commonly ordered at an annual health visit, including cholesterol and lipids, as well as kidney function tests to assess overall health.
₹1,250.00Original price was: ₹1,250.00.₹1,000.00Current price is: ₹1,000.00.
Type 1 Diabetes mellitus (insulin-dependent diabetes mellitus, IDDM) is the result of a T-cell mediated destruction of the beta cells in genetically predisposed individuals. Autoantibodies to a variety of islet cell antigens appear during the course of autoimmune insulitis. Type 1 Diabetes is characterized by the presence of distinct circulating autoantibodies including autoantibodies to glutamic acid decarboxylase (GAD), protein tyrosine phosphatase (IA2), insulin, Zinc transport 8 (ZnT8) antibody and autoantibodies directed against cytoplasmic components of islet cells. Measurement of autoantibodies to GAD, IA2, insulin, ZnT8 and of cytoplasmic islet cell antigens (ICA) has been shown to be of significant value for the diagnosis and prediction of type 1 diabetes in first-degree relatives of diabetic patients. ZnT8 antibody complements GAD-65, IA-2, and insulin antibodies as it is positive in 3% to 4% of patients who are negative for GAD-65, IA-2, and insulin antibodies. Use of these 4 antibodies results in 93% to 98% sensitivity. One or several of these autoantibodies are found in most new onset type 1 diabetic patients. They can also be detected before the onset of the disease and characterize the so-called prediabetic period. These autoantibodies help to estimate the risk of an individual developing type 1 diabetes. Testing for all autoantibodies is highly recommended for risk assessment of type 1 diabetes.
₹10,500.00Original price was: ₹10,500.00.₹9,500.00Current price is: ₹9,500.00.
The first-trimester double marker test is a non-invasive prenatal blood test that checks for elevated levels of Free Beta-hCG and PAPP-A, two hormones or proteins that can indicate a higher risk of chromosomal abnormalities like Down syndrome, Edward syndrome, and Patau syndrome in the developing baby. The test provides a risk assessment, not a diagnosis, and is performed between weeks 9 and 13 of pregnancy, ideally combined with a nuchal translucency (NT) ultrasound for increased accuracy. High-risk results are typically followed up with more definitive diagnostic tests such as Non-Invasive Prenatal Testing (NIPT) or amniocentesis.
Purpose
To assess the risk of chromosomal abnormalities, specifically Down syndrome (Trisomy 21), Edward syndrome (Trisomy 18), and Patau syndrome (Trisomy 13).
To provide early information for making informed decisions about the pregnancy.
Key Components
Free Beta-hCG:A hormone whose levels are often higher in pregnancies with Down syndrome.
PAPP-A (Pregnancy-Associated Plasma Protein-A):A protein supporting fetal and placental development; lower levels can be associated with chromosomal abnormalities.
Maternal Age & Gestational Age:These factors are included in the risk calculation.
Procedure
Blood Draw:A blood sample is taken from the pregnant woman.
Nuchal Translucency (NT) Scan:An ultrasound is performed to measure the fluid-filled space at the back of the baby’s neck; a larger NT measurement can indicate a higher risk.
Combined Risk Calculation:The blood test results are combined with the NT scan findings and maternal age to calculate the overall risk.
Interpretation & Next Steps
Screening Test:
The double marker test is a screening tool, not a diagnostic one; it provides a risk assessment, not a definitive diagnosis.
Low-Risk Result:
Indicates a low likelihood of the baby having the screened chromosomal abnormalities.
High-Risk Result:
Suggests a higher probability of chromosomal abnormality and warrants further diagnostic testing.
Follow-Up Tests:
Confirmatory diagnostic tests like NIPT, amniocentesis, or chorionic villus sampling (CVS) may be recommended.
₹2,607.00Original price was: ₹2,607.00.₹2,500.00Current price is: ₹2,500.00.
